Diasorin Sustainability Profile
DiaSorin S.p.A., headquartered in Italy, is a prominent player in the global diagnostics industry, specialising in the development and production of innovative diagnostic solutions. Founded in 1968, the company has established a strong presence in major operational regions, including Europe, North America, and Asia. With a focus on immunodiagnostics and molecular diagnostics, DiaSorin offers a range of unique products, including its LIAISON® and Simplexa™ platforms, which are renowned for their accuracy and efficiency. The company has achieved significant milestones, such as expanding its product portfolio and enhancing its technological capabilities, solidifying its market position as a leader in the field. Recognised for its commitment to quality and innovation, DiaSorin continues to advance healthcare diagnostics, making a meaningful impact on patient care worldwide.
DitchCarbon Score
How does Diasorin's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Diasorin's score of 62 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Diasorin's reported carbon emissions
In 2024, DiaSorin reported total carbon emissions of approximately 226,256,000 kg CO2e globally, with emissions distributed across all three scopes: 3, 1, and 2. Specifically, Scope 1 emissions were about 3,513,000 kg CO2e, while Scope 2 emissions (market-based) totalled approximately 12,132,000 kg CO2e. Scope 3 emissions were significantly higher, at around 226,256,000 kg CO2e, indicating a substantial impact from upstream and downstream activities, particularly from purchased goods and services (about 92,053,000 kg CO2e) and the use of sold products (approximately 113,217,000 kg CO2e). In the UK, DiaSorin's emissions for 2024 were reported at approximately 248,000 kg CO2e, with Scope 1 emissions at about 80,000 kg CO2e, Scope 2 at around 16,000 kg CO2e, and Scope 3 at approximately 151,000 kg CO2e. DiaSorin has set ambitious climate commitments, aiming for Net Zero emissions by 2050. In the near term, the company projects a reduction in carbon emissions to approximately 305,010 kg CO2e by 2028, representing an 18.52% decrease from current levels. These targets reflect DiaSorin's commitment to sustainability and align with industry standards for climate action. The emissions data is sourced directly from DiaSorin S.p.A., with no cascaded data from parent or related organizations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 61,753,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 9,489.51 | 0,000.00 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | 000,000,000 |
How Carbon Intensive is Diasorin's Industry?
How Carbon Intensive is Diasorin's Location?
Diasorin's Scope 3 Categories Breakdown
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 50% of Scope 3 emissions.
Top Scope 3 Categories
Diasorin's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Diasorin has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
